Sphera Encapsulation
PrivateLast Round
M&A
Jul 9, 2024
Total Funding Raised
$20,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sphera Encapsulation operates in Healthcare & Life Sciences and is based in Verona. Its latest recorded funding round was a Grant round in July 2021.
Sphera Encapsulation is a biotechnology company that provides research and development in sustainable micro and nano-encapsulation technologies for the food, nutraceutical, agrochemical, cosmetic, and pharmaceutical sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sphera Encapsulation Comparables
Compare Sphera Encapsulation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanomnia | 93% | |
| Capsularis | 81% | |
| AnaBio Technologies | 79% |
For institutional investors. Book with your work email.
Sphera Encapsulation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jul 9, 2024 | ||||
| Grant | Jul 8, 2021 | ||||
| Accelerator | Jan 11, 2021 | ||||
| Accelerator | Sep 10, 2020 |
For institutional investors. Book with your work email.
Sphera Encapsulation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartLife | Accelerator |
| PepsiCo Nutrition Greenhouse | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 590% MoM, reaching 1.6K.
- Jan 21, 2026
Monthly visitors grew 56% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 26, 2026
As part of the BioCordelia project, Sphera Encapsulation S.r.l. plans to develop coatings from modified lignocellulosic matrices to optimize fertilizer nutrient release, with laboratory testing and scale-up to 10–20 kg for field trials.
- attends_eventSep 23, 2026
Sphera Encapsulation S.r.l. is due to take part in the 13th Central European Congress on Food (CEFood 2026), which takes place from Sep 23rd to Sep 26th '26 in Plovdiv, Bulgaria.
For institutional investors. Book with your work email.
Sphera Encapsulation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sphera Encapsulation's valuation, stock price, and market status.
Is Sphera Encapsulation a public or private company?
Sphera Encapsulation is a private company.
What is the current stock price of Sphera Encapsulation?
Sphera Encapsulation is a private company, so its shares have no public market price. Caplight tracks Sphera Encapsulation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sphera Encapsulation worth (valuation)?
Valuation information for Sphera Encapsulation is not publicly available.
Can I buy Sphera Encapsulation stock?
Sphera Encapsulation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sphera Encapsulation's last funding round?
Sphera Encapsulation's most recent funding round was M&A on July 9, 2024.
Who are the main investors in Sphera Encapsulation?
Key investors in Sphera Encapsulation include StartLife, PepsiCo Nutrition Greenhouse.
Will Sphera Encapsulation IPO soon?
No public IPO plans have been announced for Sphera Encapsulation.
How can I track Sphera Encapsulation secondary market activity?
Caplight tracks bids, offers, and trades in Sphera Encapsulation's shares on secondary markets.